P

ProQR Therapeutics NV
D

PRQR

2.64000
USD
-0.01
(-0.19%)
Market Open
Volume
7,979
EPS
-0
Div Yield
-
P/E
-8
Market Cap
279,594,269
OverviewSignalsIdeasNews
Related Instruments
    A
    AXSM
    -5.015
    (-5.52%)
    85.825 USD
    C
    CRBP
    -0.170
    (-1.31%)
    12.790 USD
    C
    CYTK
    0.335
    (0.69%)
    49.225 USD
    G
    GLPG
    0.290
    (1.08%)
    27.020 USD
    NVS
    NVS
    1.070
    (1.10%)
    98.150 USD
    S
    SAGE
    -0.11500
    (-2.05%)
    5.49500 USD
    V
    VKTX
    -0.610
    (-1.44%)
    41.660 USD
    More
News

Title: ProQR Therapeutics NV

Sector: Healthcare
Industry: Biotechnology
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.